Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek C Goodoory

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Alimentary Pharmacology & Therapeutics|December 25, 2025
Stability of Classification Systems for Irritable Bowel SyndromeMais Khasawneh, Vivek C Goodoory, Cho Ee Ng, et al.
Neurogastroenterology and Motility|September 30, 2025
Epidemiology of Meal-Related Abdominal Discomfort or Pain in Irritable Bowel SyndromeMelanie S Cuffe, Vivek C Goodoory, Cho Ee Ng, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2022
Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndromeVivek C Goodoory, Elspeth A Guthrie, Cho E Ng, et al.
Neurogastroenterology and Motility|October 6, 2021
Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up studyVivek C Goodoory, Orla F Craig, David J Gracie, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' replyVivek C Goodoory, Elspeth A Guthrie, Cho Ee Ng, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2023
Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here? Authors' replyVivek C Goodoory, Elspeth A Guthrie, Cho Ee Ng, et al.
Gut|June 26, 2026
Efficacy of gut-brain neuromodulators and brain-gut behaviour therapies for irritable bowel syndrome: systematic review and network meta-analysisMais Khasawneh, Elyse R Thakur, Vivek C Goodoory, et al.
The American Journal of Gastroenterology|April 12, 2021
Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel SyndromeVivek C Goodoory, Antonina Mikocka-Walus, Yan Yiannakou, et al.
Gastroenterology|August 4, 2023
Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysisVivek C Goodoory, Mais Khasawneh, Christopher J Black, et al.
Neurogastroenterology and Motility|February 6, 2024
Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burdenMais Khasawneh, Fahad Ali Shaikh, Cho Ee Ng, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Alimentary Pharmacology & Therapeutics|December 25, 2025
Stability of Classification Systems for Irritable Bowel SyndromeMais Khasawneh, Vivek C Goodoory, Cho Ee Ng, et al.
Neurogastroenterology and Motility|September 30, 2025
Epidemiology of Meal-Related Abdominal Discomfort or Pain in Irritable Bowel SyndromeMelanie S Cuffe, Vivek C Goodoory, Cho Ee Ng, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2022
Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndromeVivek C Goodoory, Elspeth A Guthrie, Cho E Ng, et al.
Neurogastroenterology and Motility|October 6, 2021
Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up studyVivek C Goodoory, Orla F Craig, David J Gracie, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' replyVivek C Goodoory, Elspeth A Guthrie, Cho Ee Ng, et al.
Alimentary Pharmacology & Therapeutics|February 23, 2023
Editorial: definition of factors associated with poor quality of life in patients with IBS-but where to from here? Authors' replyVivek C Goodoory, Elspeth A Guthrie, Cho Ee Ng, et al.
Gut|June 26, 2026
Efficacy of gut-brain neuromodulators and brain-gut behaviour therapies for irritable bowel syndrome: systematic review and network meta-analysisMais Khasawneh, Elyse R Thakur, Vivek C Goodoory, et al.
The American Journal of Gastroenterology|April 12, 2021
Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel SyndromeVivek C Goodoory, Antonina Mikocka-Walus, Yan Yiannakou, et al.
Gastroenterology|August 4, 2023
Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysisVivek C Goodoory, Mais Khasawneh, Christopher J Black, et al.
Neurogastroenterology and Motility|February 6, 2024
Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burdenMais Khasawneh, Fahad Ali Shaikh, Cho Ee Ng, et al.
Pageof 4